PharmaShots | Incisive News in 3 Shots

Subscribe Now

Advisory Committee

$GSK's Belantamab Mafodotin Receives the US FDA Advisory Committee's Recommendation to Treat Relapsed/Refractory Multiple Myeloma$

GSK's Belantamab Mafodotin Receives the US FDA Advisory Committee's Recommendation to Treat Relapsed/Refractory Multiple Myeloma

July 15, 2020

Merck Receives the US FDA Advisory Committee's Recommendation on Approval of Keytruda (pembrolizumab) for Patients with High-Risk Non-Muscle Invasive Bladder Cancer

Merck Receives the US FDA Advisory Committee's Recommendation on Approval of Keytruda (pembrolizumab) for Patients with High-Risk...

December 18, 2019

AstraZeneca and Merck & Co Receive the US FDA Advisory Committee's Recommendation on Approval of Lynparza (olaparib) as 1L Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancr

AstraZeneca and Merck & Co Receive the US FDA Advisory Committee's Recommendation on Approval of Lynparza (olaparib) as 1L Mai...

December 18, 2019

Gilead Sciences Receives the US FDA Advisory Committee's Recommendation on Approval of Descovy for PrEP

Gilead Sciences Receives the US FDA Advisory Committee's Recommendation on Approval of Descovy for PrEP

August 8, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us